CLINODISIDE A

CAS No. 916347-31-4

CLINODISIDE A( —— )

Catalog No. M19260 CAS No. 916347-31-4

Clinodiside A in rats with one compartment open model into the body, rapid distribution, elimination rate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 88 In Stock
25MG 161 In Stock
50MG 235 In Stock
100MG 352 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CLINODISIDE A
  • Note
    Research use only, not for human use.
  • Brief Description
    Clinodiside A in rats with one compartment open model into the body, rapid distribution, elimination rate.
  • Description
    Clinodiside A in rats with one compartment open model into the body, rapid distribution, elimination rate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    916347-31-4
  • Formula Weight
    959.13
  • Molecular Formula
    C48H78O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (104.26 mM)
  • SMILES
    O1C(C(C(C(C1CO)O)O)O)OCC1OC(C(C(C1OC1OC(C(C(C1O)O)O)CO)O)O)OC1CCC2(C(C1)C(CC1(C3(CC(C4(CCC(CC4=C3C=CC21)(C)C)CO)O)C)C)(C)CO)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xue SR,et al. Triterpenoid saponins from Clinopodium polycephalum. Phytochemistry. 1992 Mar;31(3):1049-50.
molnova catalog
related products
  • CKI-7

    CKI-7 2HCl is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor.

  • Ripasudil free base

    Ripasudil free base is a selective and potent ROCK inhibitor is a novel and potent antiglaucoma agent.

  • CID-5056270

    CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer.